Submitted:

09 October 2024

Posted:

10 October 2024

Withdrawn:

17 January 2025

You are already at the latest version

Subscription

Notify me about updates to this article or when a peer-reviewed version is published.

This preprint has been withdrawn

Preprint

Review

This version is not peer-reviewed.

Withdrawn: Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review

A peer-reviewed version of this preprint was published in:

Cancers 2025, 17(7), 1235. https://doi.org/10.3390/cancers17071235

Withdrawal Statement

The preprint has been withdrawn.

Submitted:

09 October 2024

Posted:

10 October 2024

Withdrawn:

17 January 2025

You are already at the latest version

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.